MarketCapExport financials
Chimerix (CMRX)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Chimerix Financial Ratios 2024-2010 | CMRX
Brief overview of Chimerix's market valuation
Ratios are assessed across five available annual reports in the 2019–2023 interval.
The latest available valuation ratios are P/S 319.96x (median 55.91x), P/B 0.54x (median 0.86x). The combined multiple level is about 217.2% above the company's historical norm, leaving less valuation cushion.
Current measures of operating quality are ROE -72.6%, ROA -60.5%, ROCE -79.4%. Negative returns point to losses or poor capital efficiency. Valuation multiples are less informative in this setting.
The cash cycle changed only slightly and ended at 52.5 days.
Overall assessment
Chimerix's market premium is not yet supported by strong capital returns, raising valuation risk.
Annual Financial Ratios Chimerix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | -1.3 | 0.9 | -3.2 | -6.9 | -0.8 | -1.7 | -3.2 | -3.1 | -2.9 | -22.3 | -10.6 | - | - | - |
P/S |
- | 320.0 | 4.3 | 275.9 | 55.9 | 7.6 | 16.1 | 50.1 | 41.5 | 31.4 | 327.7 | 88.1 | - | - | - |
EPS |
-1.0 | -0.9 | 2.0 | -2.0 | -0.7 | -2.0 | -1.4 | -1.5 | -1.6 | -2.7 | -1.8 | -3.6 | -5.8 | -23.5 | - |
EV (Enterprise Value) |
-6.72 M | 95.8 M | 144 M | 563 M | 265 M | 87.4 M | 48.1 M | 220 M | 196 M | 338 M | 1.21 B | 290 M | -2.08 M | 2.14 M | -3.31 M |
EBITDA per Share |
-1.08 | -1.05 | -0.69 | -2.04 | -0.71 | -2.08 | -1.46 | -1.51 | -1.66 | -2.68 | -1.78 | -1.47 | - | - | - |
EV/EBITDA |
0.1 | -1.0 | -2.4 | -3.0 | -11.1 | -0.7 | -0.5 | -2.9 | -2.4 | -2.7 | -20.5 | -10.0 | - | - | - |
PEG |
- | -0.04 | 0.05 | -0.1 | 0.47 | 0.02 | -0.32 | -0.37 | -0.08 | 0.06 | -0.44 | 0.02 | - | - | - |
P/B |
- | 0.5 | 0.6 | 8.0 | 4.1 | 0.9 | 0.7 | 1.0 | 0.9 | 1.0 | 4.8 | 3.9 | - | - | - |
P/CF |
- | -1.5 | -3.1 | -5.5 | -8.3 | -1.3 | -2.2 | -4.5 | -3.7 | -3.3 | -27.5 | -14.9 | - | - | - |
ROE % |
-72.64 | -42.53 | 67.03 | -253.82 | -59.31 | -102.39 | -39.12 | -32.00 | -27.66 | -34.99 | -21.60 | -36.99 | - | - | - |
ROA % |
-60.54 | -38.58 | 61.63 | -172.31 | -51.37 | -94.30 | -36.43 | -30.18 | -26.64 | -32.97 | -20.32 | -32.14 | - | - | - |
ROCE % |
-79.36 | -48.21 | -23.51 | -254.06 | -60.67 | -105.30 | -40.28 | -32.47 | -28.18 | -35.21 | -21.42 | -27.74 | - | - | - |
Current Ratio |
6.0 | 10.8 | 12.4 | 3.1 | 7.5 | 12.8 | 14.6 | 11.9 | 23.4 | 11.3 | 13.9 | 11.1 | - | - | - |
DSO |
52.5 | 588.1 | 5.6 | 31.4 | 53.4 | 45.4 | 29.8 | 185.4 | 151.8 | 105.2 | 59.5 | 20.7 | - | - | - |
DPO |
- | - | 2377.0 | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
52.5 | 588.1 | 5.6 | 31.4 | 53.4 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
52.5 | 588.1 | -2371.4 | 31.4 | 53.4 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Chimerix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.26 | -0.23 | -0.25 | - | -0.27 | -0.21 | -0.24 | - | 2.75 | -0.27 | -0.28 | -0.45 | -0.21 | -0.21 | -1.21 | -0.19 | -0.18 | -0.16 | -0.17 | -0.06 | -1.26 | -0.35 | -0.35 | -0.29 | -0.33 | -0.39 | -0.42 | -0.41 | -0.37 | -0.36 | -0.38 | -0.32 | -0.37 | -0.39 | -0.57 | -0.82 | -0.7 | -0.59 | -0.54 | -0.52 | -0.47 | -0.39 | -0.39 | -0.31 | -0.26 | -0.91 | -22.58 | -3.9 | 6.7 | -3.44 | -5.14 | - | - | - | - |
EBITDA per Share |
-0.28 | -0.25 | -0.27 | - | -0.3 | -0.24 | -0.27 | - | 0.13 | -0.27 | -0.28 | -0.45 | -0.21 | -0.21 | -1.21 | -0.19 | -0.18 | -0.16 | -0.17 | -0.06 | -1.27 | -0.36 | -0.37 | -0.3 | -0.33 | -0.39 | -0.42 | -0.39 | -0.36 | -0.36 | -0.39 | -0.33 | -0.36 | -0.39 | -0.57 | -0.83 | -0.7 | -0.59 | -0.54 | -0.52 | -0.47 | -0.38 | -0.38 | -0.3 | -0.24 | -0.33 | -4.22 | -2.7 | 7.51 | -2.82 | -3.57 | - | - | - | - |
ROE % |
-54.22 | -45.66 | -41.26 | -28.70 | 59.41 | -13.11 | -56.64 | -47.74 | -105.61 | -211.46 | -142.34 | -163.41 | -121.45 | -117.43 | -113.27 | -50.70 | -37.97 | -90.11 | -91.20 | -91.65 | -96.89 | -39.53 | -37.42 | -36.29 | -36.54 | -35.34 | -32.30 | -29.40 | -26.14 | -24.76 | -24.13 | -25.76 | -31.63 | -34.47 | -34.63 | -34.91 | -31.00 | -31.83 | -31.77 | -34.71 | -35.63 | -32.41 | -45.20 | -8.04 | 4.53 | 5.00 | 29.12 | 11.26 | -5.91 | 5.17 | 7.72 | - | - | - | - |
ROA % |
-47.92 | -41.21 | -37.89 | -26.62 | 55.51 | 22.34 | -7.75 | 0.51 | -38.77 | -134.82 | -103.11 | -126.71 | -101.20 | -99.49 | -97.24 | -45.50 | -34.66 | -80.17 | -81.12 | -81.39 | -86.30 | -36.67 | -35.14 | -34.42 | -34.76 | -33.70 | -30.91 | -28.20 | -25.24 | -23.93 | -23.30 | -24.88 | -30.30 | -32.86 | -32.90 | -32.93 | -29.23 | -29.68 | -29.53 | -31.57 | -31.84 | -28.68 | -39.58 | -160.93 | -167.23 | -143.01 | -142.69 | -35.52 | 18.64 | -16.31 | -24.35 | - | - | - | - |
ROCE % |
-59.76 | -51.02 | -46.42 | -32.42 | -28.16 | -99.31 | -141.61 | -131.53 | -189.45 | -211.48 | -142.48 | -163.57 | -121.68 | -117.79 | -113.88 | -51.77 | -39.27 | -91.97 | -93.47 | -94.14 | -99.30 | -41.53 | -39.00 | -37.40 | -37.15 | -35.87 | -32.76 | -29.83 | -26.97 | -25.47 | -24.74 | -26.29 | -32.12 | -34.91 | -34.98 | -35.16 | -31.13 | -31.83 | -31.66 | -34.36 | -35.09 | -31.66 | -32.48 | -16.28 | -4.08 | -9.11 | 2.16 | 2.75 | -11.16 | 4.38 | 5.43 | - | - | - | - |
Current Ratio |
6.9 | 7.8 | 9.7 | 10.8 | 13.3 | 14.2 | 14.2 | 12.4 | 14.8 | 2.1 | 3.7 | 3.1 | 4.6 | 5.3 | 6.3 | 7.5 | 9.1 | 11.9 | 16.0 | 12.7 | 8.1 | 11.4 | 13.0 | 14.6 | 20.8 | 21.0 | 23.3 | 17.5 | 26.8 | 32.1 | 30.2 | 27.2 | 30.0 | 28.7 | 30.8 | 17.3 | 18.4 | 19.0 | 16.5 | 16.9 | 11.2 | 14.6 | 8.2 | 7.6 | 8.0 | 8.2 | 0.9 | 1.3 | 1.3 | 1.3 | 1.3 | - | - | - | - |
DSO |
498.4 | 46.0 | - | - | 153.5 | 1217.8 | 275.4 | - | 0.7 | - | - | 52.6 | 38.0 | 60.4 | 26.1 | 29.2 | 21.1 | 47.1 | 85.0 | 20.6 | 60.5 | 69.8 | 34.0 | 6.2 | 68.1 | 24.7 | 121.7 | 48.3 | 99.3 | 168.5 | 102.0 | 45.6 | 48.4 | 21.8 | 111.4 | 43.4 | 57.0 | 36.2 | 39.9 | 39.8 | 45.8 | 18.7 | 19.7 | 22.7 | 13.7 | 74.0 | 51.8 | 19.9 | 3.4 | 11.5 | 11.6 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | 565.3 | - | 2467.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | 688.5 | - | 2514.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
498.4 | 46.0 | - | - | 153.5 | 1217.8 | 275.4 | - | 566.0 | - | 2467.8 | 52.6 | 38.0 | 60.4 | 26.1 | 27.7 | 19.3 | 22.1 | 57.8 | 16.6 | 57.5 | 78.2 | 30.3 | 6.2 | 81.6 | 25.2 | 116.2 | 83.2 | 171.1 | 227.4 | 138.9 | 73.7 | 223.4 | 79.3 | 149.8 | 71.4 | 97.7 | 53.6 | 93.5 | 8.4 | 8.2 | 10.5 | 20.7 | 25.8 | 24.8 | 28.0 | 26.6 | 19.9 | 3.4 | 11.5 | 11.6 | - | - | - | - |
Cash Conversion Cycle |
498.4 | 46.0 | - | - | 153.5 | 1217.8 | 275.4 | - | -122.5 | - | -46.4 | 52.6 | 38.0 | 60.4 | 26.1 | 27.7 | 19.3 | 22.1 | 57.8 | 16.6 | 57.5 | 78.2 | 30.3 | 6.2 | 81.6 | 25.2 | 116.2 | 83.2 | 171.1 | 227.4 | 138.9 | 73.7 | 223.4 | 79.3 | 149.8 | 71.4 | 97.7 | 53.6 | 93.5 | 8.4 | 8.2 | 10.5 | 20.7 | 25.8 | 24.8 | 28.0 | 26.6 | 19.9 | 3.4 | 11.5 | 11.6 | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Chimerix, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Britain
Israel
Germany
Canada
Russia
Schweiz
